← All organizations
Highest phase reached
Phase 3
First clinical trial
Feb 1, 2015Last known activity
Jun 25, 2018
Timeline
2010s
- Jun 1, 2013
Hepion Pharmaceuticals— Founded
- May 31, 2016
Ciclofilin Pharmaceuticals— Acquired
Drugs by trial phase (5 distinct, 7 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Subsidiaries (1 direct, 1 total across the full acquisition tree)
Recent trials (12)
- NCT03596697Study chairPhase 1Jun 25, 2018
- NCT03596697Lead sponsorPhase 1Jun 25, 2018
- NCT03284164Study chairPhase 1Sep 28, 2017
- NCT03284164Lead sponsorPhase 1Sep 28, 2017
- NCT03279146Study chairPhase 1Sep 6, 2017
- NCT03279146Lead sponsorPhase 1Sep 6, 2017
- NCT02710604Study chairPhase 2May 1, 2016
- NCT02710604Lead sponsorPhase 2May 1, 2016
- NCT02585440Study chairPhase 1Apr 1, 2016
- NCT02585440Lead sponsorPhase 1Apr 1, 2016
- NCT02412917Lead sponsorPhase 3Jun 1, 2015
- NCT02322957Lead sponsorPhase 1Feb 1, 2015
Details
- Founded
- Edison, NJ, US Jun 1, 2013
- Last known activity
- Jun 25, 2018